- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hemostatic Agents in New Zealand
Total 1073 results
-
Memorial Sloan Kettering Cancer CenterRecruitingPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Ajai ChariAmgenCompletedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedChild Abuse | Parent-Child Relations | Parenting | Parents | Addiction | Child Neglect | Substance Abuse Drug Chronic | Child Neglect Emotional | Parent-Child Problem | Parent / Child Problem | Parenteral Drug AbuseUnited States
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
Ajai ChariCelgene CorporationCompletedMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Clinic RoderbirkenUnknown
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Rajshekhar Chakraborty, MDHope FoundationRecruiting
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
University of NebraskaRecruiting
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedHead and Neck Cancer | Mucositis | Xerostomia | Radiation Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
SkylineDxMedex15Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDiarrhea | Multiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiRecruiting
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
AbbottBristol-Myers SquibbTerminated
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Celgene Corporation; University... and other collaboratorsCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSpectrum Pharmaceuticals, IncActive, not recruitingMultiple Myeloma | AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoTerminatedMultiple Myeloma | Patient ParticipationUnited States
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncTerminatedRefractory Multiple Myeloma | Myeloma | Myeloma MultipleUnited States
-
Shi, Patricia, M.D.Genzyme, a Sanofi CompanyUnknownMultiple Myeloma | Non-Hodgkins LymphomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | HDT-AHCTUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Daiichi Sankyo, Inc.PXE InternationalActive, not recruitingPseudoxanthoma ElasticumUnited States, Netherlands
-
Regeneron PharmaceuticalsActive, not recruitingRelapsed and Refractory Multiple Myeloma (RRMM)United States
-
Roswell Park Cancer InstituteTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Novartis PharmaceuticalsTerminatedCardiovascular EventsColombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
-
Mark LebwohlCompletedPseudoxanthoma ElasticumUnited States
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
GPCR Therapeutics, Inc.Recruiting